Veeva Systems announced the acquisition of Ostro, an AI-driven brand engagement platform for the life sciences industry, in a deal valued at approximately $100 million in cash and equity retention grants.

Ostro’s technology enables pharmaceutical brands to provide patients and healthcare professionals with real-time answers through AI-powered chat interfaces on brand websites. The platform uses conversational AI, semantic search and industry-specific compliance controls to deliver responses drawn from approved medical, legal and regulatory (MLR) materials.

Following the acquisition, Ostro will operate as an independent unit led by its CEO Chase Feiger. Veeva plans to integrate Ostro over time with its Commercial Cloud applications to connect digital engagement with field sales and medical interactions, helping life sciences companies improve customer engagement and access to trusted health information.
PRNewswire